A carregar...
Idarubicin-bromelain combination sensitizes cancer cells to conventional chemotherapy
OBJECTIVE(S): The primary cytotoxic effects of anticancer drugs like idarubicin, a chemotherapeutic agent, are not limited to neoplastic cells; they also produce similar effects in normal cells. In this study, we hypothesized that the combination of idarubicin-bromelain could make cancer cells more...
Na minha lista:
| Publicado no: | Iran J Basic Med Sci |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Mashhad University of Medical Sciences
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6885387/ https://ncbi.nlm.nih.gov/pubmed/31998459 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.22038/ijbms.2019.37884.9003 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|